Piperazine derivatives and their use as synthesis intermediates

Details for Australian Patent Application No. 2004205494 (hide)

Owner UCB Farchim SA

Inventors Bouvy, Didier; Ates, Celal; Cavoy, Emile

Agent Watermark

Pub. Number AU-B-2004205494

PCT Pub. Number WO2004/065360

Priority 03001565.5 23.01.03 EP

Filing date 20 January 2004

Wipo publication date 5 August 2004

Acceptance publication date 30 April 2009

International Classifications

C07D 271/07 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 295/15 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/065360 Priority application(s): WO2004/065360

30 April 2009 Application Accepted

  Published as AU-B-2004205494

27 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004205504-Diazepanes derivatives useful as LFA inhibitors

2004205483-Crystalline modification of a manganese complex